LEE TIEN-LI (Chief Executive Officer) purchased 1.3% of their position (20K shares) of AARDVARK THERAPEUTICS, INC. on the open market
Open‑market purchase worth $160.7K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/12/2025ACC: 0001193125-25-202490
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
+20K
Net shares
Net buyer
$160.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
20K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+9K
Price / share
$7.91
Trade value
$71.21K
% of position
0.6%
9/10/2025
1.51M→1.52M
Common Stock
Direct
Shares
+6K
Price / share
$7.82
Trade value
$46.93K
% of position
0.4%
9/11/2025
1.52M→1.53M
Common Stock
Direct
Shares
+5K
Price / share
$8.50
Trade value
$42.52K
% of position
0.3%
9/12/2025
1.53M→1.53M
Total
Net shares
+20K
Net value
$160.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2025 | P · Purchase | +9K | $7.91 | $71.21K | 0.6% | 1.51M | 1.52M |
| Common Stock Direct | 9/11/2025 | P · Purchase | +6K | $7.82 | $46.93K | 0.4% | 1.52M | 1.53M |
| Common Stock Direct | 9/12/2025 | P · Purchase | +5K | $8.50 | $42.52K | 0.3% | 1.53M | 1.53M |
| Total | +20K | $160.65K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.47M
Total
1.47M indirect1.47M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.47M | Indirect |
| Total | 1.47M | 1.47M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported